Rankings
▼
Calendar
ACRS Q4 2023 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ACRS
Aclaris Therapeutics, Inc.
$435M
Q4 2023 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$18M
+126.6% YoY
Gross Profit
$11M
63.4% margin
Operating Income
-$4M
-23.0% margin
Net Income
-$1M
-8.5% margin
EPS (Diluted)
$-0.02
QoQ Revenue Growth
+89.3%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$197M
Total Liabilities
$40M
Stockholders' Equity
$157M
Cash & Equivalents
$40M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$18M
$8M
+126.6%
Gross Profit
$11M
$6M
+78.6%
Operating Income
-$4M
-$29M
+86.1%
Net Income
-$1M
-$28M
+94.6%
Revenue Segments
License and Service
$26M
95%
Contract research
$1M
5%
← FY 2023
All Quarters
Q1 2024 →